Relationship between the intracellular cyclic adenosine 3':5'-monophosphate level of tumor cells and their sensitivity to killing by antibody and complement
- PMID: 222445
Relationship between the intracellular cyclic adenosine 3':5'-monophosphate level of tumor cells and their sensitivity to killing by antibody and complement
Abstract
Metabolic inhibitors which have been shown to increase the sensitivity of the guinea pig hepatoma, line 10, to antibody-guinea pig complement killing were tested for their effect on the intracellular cyclic adenosine 3':5'-monophosphate (cAMP) level of the line 10 cells. It was found that cells rendered sensitive to antibody-guinea pig complement killing following drug treatment showed a decrease in their intracellular cAMP levels. Increased susceptibility to lysis was always associated with decreased intracellular cAMP levels. Optimal doses of certain inhibitors effectively increased the sensitivity of the cells to complement-dependent lysis and decreased the intracellular cAMP levels. Other drugs which did not increase sensitivity of the cells to lysis also failed to decrease the intracellular cAMP levels. No experimental conditions were found in which intracellular cAMP levels were decreased without an increase in the susceptibility of the cells to antibody-guinea pig complement killing.
Similar articles
-
Enhancing effect by metabolic inhibitors on the killing of tumor cells by antibody and complement.Cancer Res. 1975 Nov;35(11 Pt 1):3195-203. Cancer Res. 1975. PMID: 52404
-
Inhibition of antibody-complement-mediated killing of tumor cells by hormones.Cancer Res. 1976 Oct;36(10):3672-7. Cancer Res. 1976. PMID: 182362
-
Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.Cancer Res. 1977 May;37(5):1432-7. Cancer Res. 1977. PMID: 192450
-
Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.Crit Rev Immunol. 1981 Jan;1(3):165-209. Crit Rev Immunol. 1981. PMID: 6174273 Review.
-
Molecular interactions of cells with antibody and complement: influence of metabolic and physical properties of the target on the outcome of humoral immune attack.Contemp Top Mol Immunol. 1978;7:153-80. doi: 10.1007/978-1-4757-0779-3_5. Contemp Top Mol Immunol. 1978. PMID: 215378 Review. No abstract available.
Cited by
-
Complement Membrane Attack and Tumorigenesis: A SYSTEMS BIOLOGY APPROACH.J Biol Chem. 2016 Jul 15;291(29):14927-38. doi: 10.1074/jbc.M115.708446. Epub 2016 May 19. J Biol Chem. 2016. PMID: 27226542 Free PMC article.
-
Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.Biochem J. 1989 Nov 15;264(1):1-14. doi: 10.1042/bj2640001. Biochem J. 1989. PMID: 2690818 Free PMC article. Review. No abstract available.
-
Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.BMC Infect Dis. 2018 Feb 9;18(1):74. doi: 10.1186/s12879-018-2964-5. BMC Infect Dis. 2018. PMID: 29426304 Free PMC article. Clinical Trial.
-
Adriamycin inhibits PTH-mediated but not PGE2-mediated stimulation of cyclic AMP formation in isolated bone cells.Calcif Tissue Int. 1984 May;36(3):279-84. doi: 10.1007/BF02405331. Calcif Tissue Int. 1984. PMID: 6088009